Life science executives: We can feel the lack of traveling salespeople
Novo Nordisk and Coloplast have both experienced the necessity of salespeople pitching products in person, whereas Teva's Kåre Schultz highlights differences in the markets.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Although virtual meetings have become more widespread, also when selling medicine, Danish pharmaceutical company Novo Nordisk's experience with launching diabetes tablet Rybelsus has shown that they are not sufficient, according to Danish newspaper Børsen.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk expands obesity business in spite of obstacles
For subscribers
Coloplast raises EBIT margin guidance
For subscribers
